Active Ingredient: HALOBETASOL PROPIONATE
Proprietary Name: BRYHALI
Dosage Form; Route of Administration: LOTION; TOPICAL
Strength: 0.01%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209355
Product Number: 001
Approval Date: Nov 6, 2018
Applicant Holder Full Name: BAUSCH HEALTH AMERICAS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
